Press Releases :: Nighthawk Biosciences, Inc. (SCPX)

Jan 20, 2021 7:30am EST

Heat Biologics CEO to Participate in a Fireside Chat at the B. Riley Securities Oncology Investor Conference on Jan 21, 2021

Jan 19, 2021 7:30am EST

Heat Biologics Commences Manufacturing Process for ZVX-60

Jan 11, 2021 8:00am EST

Heat Biologics Promotes William L. Ostrander to Chief Financial Officer

Jan 08, 2021 4:00pm EST

Heat Biologics to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference

Dec 16, 2020 7:30am EST

Heat Biologics Announces Completion of ZVX-60 Vaccine Cell Line for COVID-19

Dec 10, 2020 8:00am EST

Heat Biologics Provides Business Update

Nov 09, 2020 7:00am EST

Heat Biologics Provides Third Quarter 2020 Business Update

Oct 07, 2020 7:30am EDT

Heat Biologics Issued Additional Patent on gp96 Combination Platform Therapy with T-cell Co-Stimulator

Sep 09, 2020 7:30am EDT

Heat Biologics CEO to Participate in Virtual Panel: "New Approaches to COVID-19: Hidden Breakthroughs," on Thursday, September 10th

Sep 02, 2020 7:30am EDT

Heat Biologics Issued Key Patent on Combination Platform Therapy

rss_feed News RSS